Category: Business

(SeaPRwire) - SHENZHEN, China, May 13, 2026 -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, announced today that it will release its unaudited financial results for the first quarter ended March 31, 2026 before the opening of U.S. markets on Tuesday, May 26, 2026. The company's management will hold an earnings conference call on Tuesday, May 26, 2026, at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Beijing time on the same day). All participants must register in advance to join the conference using the link provided below. Please dial in 15 minutes prior to the scheduled start time. Conference access details will be sent upon registration. Participant Online Registration: https://register-conf.media-server.com/register/BI1e348d0587ca40d88837f3c15b435b90 A live and archived webcast of the conference call will be available on the Investor Relations section of Aurora Mobile’s website at https://ir.jiguang.cn/. About Aurora Mobile Limited Established in 2011, Aurora Mobile (NASDAQ: JG) is a leading provider of customer engagement and marketing technology services. The Company is committed to empowering global enterprises with reliable, efficient, and intelligent customer interaction solutions. Building on its early leadership in mobile messaging, Aurora Mobile has developed into a comprehensive platform integrating Omnichannel Engagement, AI-Driven Marketing, Advanced AI Customer Support, and Frictionless Identity Security. Through its flagship brand EngageLab and its advanced AI infrastructure GPTBots.ai, the Company enables businesses to achieve seamless customer reach, automate intricate marketing workflows, and enhance service efficiency with AI agents, driving digital transformation for clients worldwide. For more information, please visit https://ir.jiguang.cn/ For more information, please contact: Aurora Mobile LimitedEmail: ir@aurora-mobile.com Christensen AdvisoryMs. Xiaoyan SuEmail: Xiaoyan.Su@christensencomms.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - WUHAN, China, May 13, 2026 -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, participated in the 2026 National Medical Industry Academic and Industry Integration Conference, held from May 6 to 9 in Wuhan. At the health management sub-forum, Fangzhou presented its innovative “AI+Chronic Disease Service” solutions, addressing some of the most pressing challenges in chronic disease care. AI+H2H Ecosystem Underpins Full-Cycle Chronic Disease Care In response to persistent challenges facing the healthcare industry, such as physicians’ time constraints, limited patient awareness of chronic disease risks, and poor medication adherence, Fangzhou emphasized the importance of integrated care that connects the hospital and the home. Drawing on a network of 251,000 registered doctors and a robust technology platform, the Company’s AI+H2H (Hospital-to-Home) ecosystem supports a full-cycle approach to chronic disease management. Intelligent tools such as AI Health Assistants and AI Doctor Assistants streamline post-clinic follow-up, improve access to services, and extend care to more patients. A Fangzhou executive commented at the sub-forum: “Chronic disease management must bridge the gap between hospital and home by becoming part of patients’ everyday lives. Our AI+H2H approach helps deliver long-term care that is coordinated, consistent, and personalized for every patient.” Personalized Follow-Up Delivers Tangible Outcomes Chronic disease management requires long-term engagement. Fangzhou centers its approach on structured follow-ups, evolving from one-off consultations to continuous care over the full course of a patient’s condition. AI-powered tools further improve efficiency. Patient feedback and assessment data are aggregated and reviewed to generate health reports for physicians, significantly reducing the administrative burden without sacrificing quality of care. Long-term members also gain access to tailored health plans, dynamic monitoring, early-warning alerts, and individualized medication guidance, ensuring truly comprehensive, ongoing support. Strengthening its Role as a Trusted Long-Term Health Partner In line with trends in intelligent healthcare and collaboration between industry and academia, Fangzhou continues to refine its AI+Chronic Disease Care ecosystem, broadening its service capabilities and enhancing the patient experience. The Company aims to be a trusted long-term health partner, using technology to deliver accessible, high-quality chronic disease management and to set a benchmark for sustainable innovation in healthcare. About Fangzhou Inc. Fangzhou Inc. (HKEX: 06086) is China’s leading online chronic disease management platform, serving 56.4 million registered users and 251,000 physicians (as of December 31, 2025). The Company specializes in delivering tailored medical care and AI-enabled precision medicine solutions. For more information, visit https://investors.jianke.com. Media Contact For further inquiries or interview requests, please contact: Xingwei ZhaoDirector of Public RelationsEmail: pr@jianke.com Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements. This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - VANCOUVER, British Columbia, May 12, 2026 — HMS Bergbau AG (the “Acquiror”), a German public commodities marketing company, announces that on May 12, 2026, it acquired a total of 43,300,000 Common Shares of Belmont Resources Inc. (the “Issuer”) from three existing shareholders of the Issuer (the “Vendors”) through private agreements, for total consideration of $1,737,940 paid by the Acquiror to the Vendors. Specifically, the Acquiror purchased 18,000,000 Common Shares from ERAG Energie & Rohstoff AG PCC (“ERAG”) at a price of $0.0333 per share, 7,300,000 Common Shares from LaVo Verwaltungsgesellschaft MBH (“LaVo”) at $0.045 per share, and 18,000,000 Common Shares from Commodities and Resources Pte. Ltd. (“C&R”) at $0.045 per share. ERAG and LaVo, two of the three Vendors, are associated parties with respect to the Acquiror. Prior to the closing of these transactions, the Acquiror held 24,200,000 Common Shares of the Issuer; ERAG held 18,000,000 Common Shares; and LaVo held 7,300,000 Common Shares. Combined, these holdings totaled 49,500,000 Common Shares, representing approximately 37.1% of the Issuer’s issued and outstanding Common Shares. Separately, C&R held 18,000,000 Common Shares, accounting for about 13.6% of the Issuer’s issued and outstanding Common Shares. Following completion of the purchase transactions, the Acquiror now holds 67,500,000 Common Shares of the Issuer, representing approximately 50.9% of the Issuer’s issued and outstanding Common Shares. At this time, none of ERAG, LaVo, or C&R holds any Common Shares of the Issuer. The Common Shares were acquired by the Acquiror for business and investment purposes. Depending on market conditions and other factors, the Acquiror may choose to increase or decrease its beneficial ownership, control, or influence over the Issuer’s securities—whether via open market purchases, private agreements, or other means—subject to prevailing market conditions and available investment and business opportunities. The Acquiror will file an Early Warning Report in accordance with National Instrument 62-103F1 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, disclosing the aforementioned transaction to the relevant securities regulatory authorities. To obtain a copy of the early warning report filed by the Acquiror, please contact the company directly at c/o Patrick Brandl at +43 664 968 7011 or visit the Issuer’s SEDAR+ profile at www.sedarplus.ca. HMS Bergbau AG An der Wuhlheide 23212459 BerlinGermanyc/o Patrick Brandlhms@hms-ag.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - SANTA CLARA, Calif., May 12, 2026 -- Agora, Inc. (NASDAQ: API), a pioneer and leader in conversational AI and real-time engagement technology, will announce its financial results for the first quarter ended March 31, 2026 after the U.S. markets close on May 26, 2026. Agora, Inc. will conduct a conference call to discuss the financial results at 6 p.m. Pacific Time / 9 p.m. Eastern Time on the same day. The following are the details for the conference call: Event title: Agora, Inc. 1Q 2026 Financial Results The call will be accessible at https://edge.media-server.com/mmc/p/vbsrxuhv Investors who wish to participate should log in at least 15 minutes before the broadcast begins. Participants can register for the call using the link below. https://register-conf.media-server.com/register/BIdac26bffc0104a0da1dfcd94c16d1908 Please visit Agora, Inc.’s investor relations website at https://investor.agora.io on May 26, 2026, to view the earnings release and accompanying slides prior to the conference call. About Agora, Inc. Agora, Inc. serves as the holding company for two distinct divisions under the Agora and Shengwang brands. Headquartered in Santa Clara, California, Agora is a pioneer and global leader in conversational AI and Real-Time Engagement Platform-as-a-Service (PaaS), offering developers simple, flexible, and powerful application programming interfaces (APIs) to integrate real-time conversational AI, video, voice, chat, and interactive streaming into their applications. Based in Shanghai, China, Shengwang is a pioneer and leading provider of conversational AI and Real-Time Engagement PaaS in the Chinese market. For more information about Agora, please visit: www.agora.ioFor more information about Shengwang, please visit: www.shengwang.cn CONTACT: Investor Contact: investor@agora.io Media Contact: press@agora.io This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - SINGAPORE, May 12, 2026 -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha" or the "Company"), a leading institutional digital asset financing platform, announced today that it will release its financial results for the first quarter of 2026 prior to the opening of the U.S. markets on May 19, 2026. The Company’s management team will host a conference call at 8:00 A.M. Eastern Time on May 19, 2026 (which corresponds to 8:00 P.M. Singapore Time on the same date) to review and discuss the financial outcomes. To participate, please register in advance at:https://register-conf.media-server.com/register/BIfb7cbcb3ef3e4019a79ca07ecd069108 After registering, attendees will receive a calendar invitation email containing the dial-in number, passcode, and a unique access PIN. A live webcast is accessible at https://edge.media-server.com/mmc/p/4jef7vmv. A replay of the call will be available on the Company’s investor relations website at https://ir.antalpha.com. About AntalphaAntalpha is a prominent fintech firm offering financing, technology, and risk management services tailored to institutions operating within the digital asset sector. Through its Antalpha Prime platform, the company provides Bitcoin supply chain and margin lending solutions, enabling clients to originate and oversee their digital asset loans while monitoring collateral positions with near real-time data. ContactsInvestor Contact: ir@antalpha.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - HONG KONG, May 12, 2026 -- Geely Automobile Holdings Limited (00175.HK) has officially published its 2025 Environmental, Social, and Governance (ESG) Report. The publication highlights the company's deep integration of its six primary strategic pillars: Climate Neutrality, Nature Positive, Inclusive Development, Comprehensive Safety, Digital & Intelligent Innovation, and Governance & Ethics. Supported by its Full-Domain AI and Full-Domain Safety technology systems, along with the green transformation of its industrial chain, the automaker realized a 25.5% decrease in full life-cycle carbon emissions per vehicle compared to the 2020 baseline. This performance exceeded the initial 25% reduction goal and represented a 9.1% year-on-year decline. Concurrently, sales of new energy vehicles (NEVs) jumped 90% year-on-year to 1.688 million units. Geely Auto also bolstered its sustainability framework, earning 15 national-level green factory certifications and 12 zero-waste factory certifications. Thanks to its comprehensive and systematic ESG efforts, Geely Auto has received significant recognition from major rating agencies, positioning itself as an ESG leader among Chinese car manufacturers. In a landmark achievement, the company was featured in the S&P Global Sustainability Yearbook 2026 (Global Edition). As the sole Chinese automaker to be included, Geely Auto has joined the global elite in the automotive manufacturing sector regarding ESG performance. Jerry Gan, CEO of Geely Auto Group, commented, “We are steadily moving toward our long-term objective of reaching carbon neutrality by 2045, fostering collaborative growth and mutual success across the value chain while building a safe, green, and sustainable ecosystem for the automotive industry.” About Geely Auto Group Geely Auto Group is a prominent global automotive manufacturer based in Hangzhou, China. Operating as a subsidiary of Zhejiang Geely Holding Group, the company produces passenger vehicles under the Geely, Lynk & Co, and Zeekr brands. In 2025, Geely Auto reached total sales of 3,024,567 units, surpassing its yearly target with a 39% year-on-year increase. Sales of new energy vehicles (NEVs) totaled 1,687,767 units, marking a 90% rise over the previous year. With a dedication to technological advancement, electrification, and sustainable transport, Geely Auto Group maintains world-class R&D and manufacturing hubs in China, Europe, and other international markets. The Group focuses on providing safe, high-quality, and intelligent vehicles powered by hybrid systems, electric architectures, smart connectivity, and autonomous driving technology. As a global entity, Geely Auto Group expands its international footprint through strategic alliances, localized production, and industry-leading platforms. Geely is committed to developing mobility solutions that are more environmentally friendly, intelligent, and accessible, shaping the future of sustainable transit. Company: Geely Automobile Holdings (HangZhou) Co.LtdContact Person: Geely Auto Group Media Relations Janet ChenEmail: media@geely.comWebsite: global.geely.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - HANGZHOU, China, May 12, 2026 -- On May 7th, the Women's Hospital, School of Medicine of Zhejiang University celebrated its 75th anniversary. Originally established as a small maternity and children’s hospital by West Lake in Hangzhou—the capital city of east China’s Zhejiang Province—it has grown into a leading medical institution operating across three modern campuses: Hubin, Qianjiang, and Yuhang. Today, it serves patients not only across Zhejiang and China but also around the world. A media snippet accompanying this announcement is available by clicking on this link. Guided by its vision “Rooted in Zhejiang, Serving China, Connecting the World,” the hospital is committed to building a world-class medical center for women’s and children’s health with Chinese characteristics. Through sustained medical innovation, it continues to deliver scalable, shareable Chinese solutions for women’s and children’s health worldwide. Pioneering Breakthroughs Through Scientific Innovation For 75 years, the hospital has upheld a simple principle: medical research must begin with patient needs and return to patient care. Focusing on globally critical fields—birth defect prevention, gynecologic oncology, high-risk pregnancy, reproductive health, and complex gynecological disorders—the hospital has achieved a series of internationally recognized breakthroughs. Its landmark research has been published in top-tier journals, including Science and BMJ, and is widely adopted by clinicians worldwide. In birth defect prevention, the hospital stands at the global forefront. By combining artificial intelligence and multi-omics technologies, its team delivered China’s first healthy baby born using an AI-assisted embryo genetic risk assessment for familial breast cancer, effectively blocking high-risk inherited genes at the pre-conception stage. The hospital also developed advanced prenatal genetic testing kits and improved non-invasive prenatal screening (NIPT), filling key technological gaps in China. It leads the China Neonatal Multi-omics Project, establishing vital baseline health data that supports global pediatric research. In precision gynecologic oncology, the hospital has redefined standards of care. It pioneered novel chemo-immunotherapy regimens for advanced ovarian and cervical cancers, significantly extending patient survival. Using single-cell multi-omics, it created a new molecular classification system for endometrial cancer, enabling truly personalized treatment. Its standardized protocols for gestational trophoblastic disease have become a national reference. The hospital runs a comprehensive lifetime health management system for women, covering adolescence, childbearing years, pregnancy, postpartum recovery, and menopause. Supported by its maternal safety program, it maintains a 100% success rate in treating critical maternal cases, helping Zhejiang sustain one of the lowest maternal mortality rates in China. Building a World-Class Ecosystem for Medical Advancement Sustained innovation relies on strong platforms, systems, and talent. Over decades, the hospital has built a leading, internationally aligned research and translation ecosystem for obstetrics and gynecology. It hosts more than 10 national and provincial-level research platforms, including the key laboratory of reproductive genetics affiliated with the Ministry of Education. These centers focus on reproductive health, birth defects, major gynecological diseases, and maternal and infant safety. The hospital operates certified research wards and a national-level biobank capable of storing millions of clinical samples, supporting high-quality medical research. Its six-in-one clinical research system shortens the cycle from lab discovery to bedside application. To accelerate real-world impact, the hospital established the Zhejiang Obstetrics and Gynecology Innovation and Translation Alliance, linking universities, industry, and hospitals to bring dozens of technologies and products into clinical use. Jointly developed with Zhejiang University, "Shanyu Large Model" is China's first AI system dedicated to obstetrics and gynecology. It supports clinical diagnosis, scientific analysis, and personalized health management, embedding artificial intelligence into routine care. The hospital nurtures talent through recruitment and development programs, supporting young researchers, postdoctoral fellows, and innovative projects. Honorary awards uphold a tradition of rigor, innovation, and compassion, forming a stable, high-performance team. Opening Doors to Global Health Cooperation Innovation at the hospital extends beyond its walls through digitalization and international cooperation. Its online maternal and child health telemedicine platform delivers high-quality care to grassroots and remote communities. Programs including 5G+VR newborn remote visitation, remote fetal heart monitoring, and internet-based maternal and infant home care have become national and provincial models. Through remote guidance, training, and intelligent follow-up, the hospital strengthens primary care services across China. Globally, the hospital partners with world-leading institutions including Harvard University, University of Cambridge, KU Leuven, and Monash University. It conducts joint research and talent training in reproductive genetics, single-cell multi-omics, and other frontier fields. Engaging with the Belt and Road initiative and developing countries, it transfers appropriate medical technologies, provides training, and performs collaborative surgeries. It shares Chinese best practices in birth defect prevention, high-risk maternal care, and gynecologic oncology with nations across Asia, Europe, and Africa. Looking ahead, the hospital is advancing six strategic programs: fertility protection, birth defect prevention, maternal and child safety, patient-centered delivery, quality improvement, and digital innovation. It aims to become an innovative, research-oriented, patient-centered hospital that enhances fertility support, improves child health, and elevates maternal and child healthcare nationwide. After 75 years of dedication and discovery, Women's Hospital, School of Medicine of Zhejiang University, remains driven by its mission to protect life and advance health. Its evolution from a local hospital into a national leader and global contributor demonstrates China's capacity to provide lasting, meaningful solutions for women and children everywhere. Source: Women's Hospital, School of Medicine of Zhejiang University CONTACT: Contact person: Ms. Li, Tel: 86-10-63074558 This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, China, May 12, 2026 -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leading player in China’s new energy vehicle sector, announced today that it will release its unaudited financial results for the first quarter of 2026 before the U.S. markets open on Thursday, May 28, 2026. The Company’s management will host an earnings conference call on Thursday, May 28, 2026, at 8:00 A.M. Eastern Time in the United States or 8:00 P.M. Beijing/Hong Kong Time on the same day. Participants interested in joining the call should register online prior to the scheduled start time using the link provided below. Upon registration, participants will receive access details for the conference call, including dial-in numbers, passcode, and a unique access PIN. To participate, simply dial the provided number, enter the passcode followed by your PIN, and you will be connected immediately. Participant Online Registration: https://s1.c-conf.com/diamondpass/10054648-why786.html A replay of the conference call will be available until June 4, 2026, by dialing the following numbers: United States:+1-855-883-1031 Chinese Mainland:+86-400-1209-216 Hong Kong, China:+852-800-930-639 International:+61-7-3107-6325 Replay PIN:10054648 A live and archived webcast of the conference call will also be accessible on the Company’s investor relations website at https://ir.lixiang.com. About Li Auto Inc. Li Auto Inc. is a leader in China’s new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric vehicles. Its mission is: Be Proactive, Change the World. Through innovations in product, technology, and business model, the Company provides families with safe, convenient, and comfortable products and services. Li Auto is a pioneer in successfully commercializing extended-range electric vehicles in China. While firmly advancing along this technological route, it builds platforms for battery electric vehicles in parallel. The Company leverages technology to create value for users. It concentrates its in-house development efforts on proprietary range extension systems, innovative electric vehicle technologies, and smart vehicle solutions. The Company started volume production in November 2019. Its current model lineup includes a high-tech flagship family MPV, four Li L series extended-range electric SUVs, and two Li i series battery electric SUVs. The Company will continue to expand its product lineup to target a broader user base. For more information, please visit: https://ir.lixiang.com. For investor and media inquiries, please contact: Li Auto Inc.Investor RelationsEmail: ir@lixiang.com Christensen AdvisoryRoger HuTel: +86-10-5900-1548Email: Li@christensencomms.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - SHANGHAI, China, May 12, 2026 -- Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) ("Qfin Holdings" or the "Company"), a leading AI-empowered Credit-Tech platform in China, today announced that it will hold an annual general meeting of shareholders (the "AGM") at 9:30 a.m. on June 30, 2026 (Beijing time) at the address of Building 1, No. 98 Qingyijiang Road, Putuo District, Shanghai 200331, People's Republic of China for the purpose of considering and, if thought fit, re-appointing Deloitte Touche Tohmatsu and Deloitte Touche Tohmatsu Certified Public Accountants LLP as the auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the board of directors of the Company to fix their remuneration for the year ending December 31, 2026. The board of directors of the Company has fixed the close of business on May 27, 2026, Hong Kong time, as the record date (the "Shares Record Date") of the Company's Class A ordinary shares with a par value of US$0.00001 each ("Class A Ordinary Shares"). Holders of record of the Class A Ordinary Shares as of the Shares Record Date are entitled to attend and vote at the AGM and any adjourned meeting thereof. Holders of record of the Company's American Depositary Shares ("ADSs") as of the close of business on May 27, 2026, New York time, who wish to exercise their voting rights for the underlying Class A Ordinary Shares represented by their ADSs must give voting instructions according to the voting instruction card received. The notice of the AGM, which sets forth the resolutions to be submitted to shareholder approval at the meeting, is available on the Company's website at: https://ir.qfin.com. About Qfin Holdings Qfin Holdings is a leading AI-empowered Credit-Tech platform in China. By leveraging its sophisticated machine learning models and data analytics capabilities, the Company provides a comprehensive suite of technology services to assist financial institutions and consumers and SMEs in the loan lifecycle, ranging from borrower acquisition, preliminary credit assessment, fund matching and post-facilitation services. The Company is dedicated to making credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions. For more information, please visit: https://ir.qfin.com. Safe Harbor Statement Any forward-looking statements contained in this announcement are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward-looking statements. Qfin Holdings may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission ("SEC"), in announcements made on the website of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including the Company's business outlook, beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, which factors include but not limited to the following: the Company's growth strategies, changes in laws, rules and regulatory environments, the recognition of the Company's brand, market acceptance of the Company's products and services, trends and developments in the credit-tech industry, governmental policies relating to the credit-tech industry, general economic conditions in China and around the globe, and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks and uncertainties is included in Qfin Holdings' filings with the SEC and announcements on the website of the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and Qfin Holdings does not undertake any obligation to update any forward-looking statement, except as required under applicable law. For more information, please contact: Qfin HoldingsE-mail: ir@qfin.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - BEIJING, May 12, 2026 -- BingEx Limited (“BingEx” or the “Company”) (Nasdaq: FLX), a leading provider of on-demand dedicated courier services in China, operating under the brand name “FlashEx,” announced today that it will release its first quarter 2026 unaudited financial results before the U.S. market opens on Thursday, May 21, 2026. The Company will conduct an earnings conference call on Thursday, May 21, 2026, at 8:00 PM Beijing Time (8:00 AM U.S. Eastern Time) to discuss these results. To participate in the conference call, attendees must pre-register at:https://register-conf.media-server.com/register/BI679071586eb64abfa7ef0cacb5cf24bd Upon successful registration, participants will receive an email containing dial-in numbers and a personal identification number (PIN) for joining the call. A live webcast of the conference call will be accessible on the Company's investor relations website at http://ir.ishansong.com, and a recording of the webcast will be available after the event. About BingEx Limited BingEx Limited (Nasdaq: FLX) is a pioneer in China's on-demand dedicated courier services sector, serving individual and business clients with exceptional punctuality, delivery security, and service quality. The company's services are branded as “FlashEx,” or “闪送,” and FlashEx has become a recognized name for on-demand dedicated courier services throughout China. With a commitment to enhancing people's lives through its services, FlashEx strives to consistently deliver a superior customer experience and provide unique value to all stakeholders in its business. For further information, please visit: http://ir.ishansong.com. Investor Relations Contact In China: BingEx LimitedInvestor RelationsE-mail: ir@ishansong.com Piacente Financial CommunicationsHelen WuTel: +86-10-6508-0677E-mail: FlashEx@thepiacentegroup.com In the United States: Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050E-mail: FlashEx@thepiacentegroup.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

The partnership unites venture creation and biologics discovery to expedite the development of novel medicines up to human clinical proof of conceptThis marks a first-of-its-kind collaboration between a specialized biotech venture firm and a publicly-traded biopharmaceutical companyInitial focus is on autoimmune diseases, utilizing bi- and tri-specific antibody approaches that integrate innovative and de-risked targets and mechanisms (SeaPRwire) - CAMBRIDGE, Mass. and TAIPEI, Taiwan, May 11, 2026 -- Delos Capital (“Delos”) and AP Biosciences, Inc. (“APBio”), today announced a strategic collaboration to establish and nurture new biotechnology companies. The initial emphasis is on the discovery and advancement of novel immune-related drug candidates through early clinical proof of concept. This model draws on Delos’ proven experience in forming and guiding biotech enterprises, combined with APBio’s fully integrated R&D capabilities and operational efficiency across Greater China, facilitating faster and more capital-efficient translation from groundbreaking concepts to clinical-stage assets. Under this collaboration, Delos, through its Delos Foundry, will oversee therapeutic ideation, financing, and strategic development. APBio, which has experience advancing molecules from discovery through pivotal Phase 3 clinical studies, will contribute its proprietary antibody discovery platform and translational expertise. "Building and leading biotech companies defines our team's core identity at Delos, which is why we are advancing our Delos Foundry," said Henry Chen, founder and managing partner of Delos. "When we do not encounter existing companies aligned with one of our investment theses, our team can bridge that gap by incubating innovative assets under a US-based NewCo. We are pleased to partner with a biologics design firm like APBio, which brings the perspective of a biopharma with full-stack R&D experience." Jeng Her, Ph.D., founder and Chief Executive Officer of APBio, added: "This collaboration enables us to amplify the impact of our antibody discovery platforms beyond our internal pipeline. By combining our biologics design capabilities with Delos' company-building expertise, we can help transform innovative therapeutic concepts into clinically validated programs via a capital-efficient and scalable framework." About Delos Capital Delos Capital is a life sciences investment firm dedicated to empowering life sciences leaders to convert bold ideas into medical breakthroughs for patients. Our team leverages diverse skills honed as operators and investors at leading biotech organizations, with extensive networks spanning the most significant biotech innovation hubs. Our rigorous investment process integrates a deep understanding of biology, proprietary AI workflows, unmet medical needs, and building high-performing companies to deliver medical breakthroughs to patients. For further information on Delos Foundry, visit www.deloscapital.com/foundry. About AP BiosciencesAP Biosciences is a clinical-stage biopharmaceutical company based in Taiwan, committed to developing innovative antibody-based therapies for cancer and other diseases. Leveraging its proprietary Omni-Mab and T-Cube platforms, APBio is pioneering next-generation bispecific antibodies designed to enable precise, tumor-targeted immune activation. The company’s pipeline includes multiple clinical-stage programs, as well as partnered assets progressing through later stages of development. For further details, visit www.apbioinc.com. AP Biosciences Investor ContactSpike LoAP Biosciencespr@apbioinc.com AP Biosciences Media ContactMike TattoryLifeSci Communicationsmtattory@lifescicomms.com Delos Capital Contactinfo@deloscapital.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.

(SeaPRwire) - CGTN published an article examining why the world is closely watching the upcoming China-US summit. Against a backdrop of prolonged geopolitical tensions and fragile global recovery, the article highlights how head-of-state diplomacy serves as the "anchor" of China-US relations. It also explores how the summit could inject greater certainty into an increasingly volatile world.BEIJING, May 11, 2026 -- At the invitation of Chinese President Xi Jinping, US President Donald Trump will pay a state visit to China from May 13 to 15, the Chinese Foreign Ministry announced on Monday.At a time of prolonged geopolitical tensions and fragile global recovery, the world is closely watching whether the two leaders can further stabilize China-US relations and inject much-needed certainty into the international landscape.Keeping China-US relations on the right courseFor many observers, the summit reflects one core hope: stability in bilateral ties.Interviews conducted by CGTN show a common view among experts that head-of-state diplomacy has long served as the "anchor" of that stability.As Wu Xinbo, dean of the Institute of International Studies at Fudan University, put it, such head-of-state diplomacy "sets the tone and defines the direction" of bilateral ties.Christopher Newport University's Associate Professor Sun Taiyi similarly noted that direct leader-to-leader communication helps reduce uncertainty, prevent miscalculation and signal that stability remains the overriding priority.Over the past year, the two leaders have maintained communication through phone calls and a face-to-face meeting in Busan, the Republic of Korea (ROK), helping prevent major miscalculations and keeping the overall relationship stable.As Xi told Trump in Busan, "In the face of winds, waves and challenges, we should stay the right course, navigate through the complex landscape, and ensure the steady sailing forward of the giant ship of China-US relations."That metaphor of "steering the ship" has been reflected in concrete progress.Since 2025, under the strategic consensus reached by the two heads of state, economic teams from both sides have held multiple rounds of talks, while large-scale tariff escalation has been paused. A new round of consultations is set to take place in the ROK from May 12 to 13, just ahead of the Beijing summit.People-to-people exchanges have also regained momentum. In April, Beijing hosted events marking the 55th anniversary of China-US "Ping-Pong Diplomacy," with hundreds of young Chinese and Americans taking part in sports and cultural exchanges. More US youth groups have also traveled to China for exchange and study programs.Bringing certainty to a changing worldAs the world's two largest economies, and with China-US relations standing as one of the most important bilateral ties globally, outcomes of head-of-state diplomacy between the two countries not only help stabilize bilateral relations, but also have a broader impact on global development and governance.As Peterson Institute Senior Fellow Chad Bown noted, "virtually everyone has a stake in the outcome." Cornell University economist Eswar Prasad went further, suggesting the meeting could carry implications for global trade, geopolitics and even the "rules-based order."CGTN interviews with experts highlight the similar points.Zhang Tengjun, associate research fellow at the China Institute of International Studies, said deeper cooperation could inject momentum into global recovery and stabilize industrial and supply chains, stressing that the trajectory of bilateral ties is closely tied to the world's future.On this point, scholar Sun said that stable relations reduce risks of supply chain disruption, financial volatility and geopolitical fragmentation.Dean Wu noted that as the world's two major technological powers, China and the United States have the capacity to generate "win-win outcomes" through practical cooperation, supporting broader global growth and scientific progress.Likewise, Cui Fan, vice dean of the University of International Business and Economics, emphasized that both countries share responsibility for the stability of global governance.Xi underlined this responsibility in Busan as well: "The world today is confronted with many tough problems. China and the United States can jointly shoulder our responsibility as major countries, and work together to accomplish more great and concrete things for the good of our two countries and the whole world."This year provides a window for that responsibility to be tested, with China hosting APEC and the United States hosting the G20 Leaders' Summit – two platforms that could open space for coordination on global recovery, food and energy security, debt risks, and governance reform.In a February phone call with Trump, Xi set out a pragmatic path forward: "If the two sides work in the same direction in the spirit of equality, respect and mutual benefit, we can surely find ways to address each other's concerns."The world will watch the upcoming summit to see how Beijing and Washington can translate into action Xi's call to "make progress step by step to build mutual trust, find the right way to get along, and make 2026 a year where the two major countries advance toward mutual respect, peaceful coexistence and win-win cooperation."https://news.cgtn.com/news/2026-05-11/Why-is-the-world-watching-the-upcoming-China-US-summit--1N3u9OWFqdq/p.htmlCONTACT: Contact: CGTN Digital cgtn@cgtn.com This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.